Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performance
On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…
On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…
On Oct. 7, 2020, Sonic Healthcare USA announced that it had launched a multiplex RT-PCR assay that combined…
On Oct. 6, 2020, National Institutes of Health (NIH) researchers announced they had found that a carbohydrate called…
On Oct. 6, 2020, clinicians and researchers from Brigham and Women’s Hospital, the Broad Institute of MIT and…
On Oct. 5, 2020, the U.S. Food and Drug Administration (FDA) announced it had awarded a research contract…
On Oct. 5, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced the existence of published…
On Oct. 5, 2020, Mateon Therapeutics announced that ArtiShieldTM had been approved for manufacture and marketing by the…
On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
On Oct. 2, 2020, Yale scientists will build the next-generation human brain PET scanner, the NeuroeXplorer (NX), to…
On Oct. 2, 2020, the World Health Organization (WHO) and the Kingdom of Saudi Arabia signed a contribution…
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
On Sept. 30, 2020, the National Institutes of Health (NIH) announced that it had awarded nearly $234 million…
On Sept. 30, 2020, the United Nations (UN) and its partners announced that nearly $1 billion in financing…
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
On Sept. 29, 2020, the Centers for Disease Control and Prevention (CDC) reported that during Aug. 2-Sept. 5,…
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the U.S. Food and Drug…
On Sept. 29, 2020, AXIM Biotechnologies announced that it has filed a provisional patent for a first-in-class face…
On Sept. 29, 2020, Windtree Therapeutics announced that U.S. Food and Drug Administration (FDA) has accepted its Investigational…
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
On Sept. 28, 2020, the World Health Organization (WHO) announced agreements to make available, for low and middle-income…
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
On Sept. 28, 2020, Hologic announced that its Panther Fusion SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 25, 2020, scientists from the University of Oxford’s Nuffield Department of Medicine published their evaluation of…
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
On Sept. 24, 2020, Lumen Bioscience and the US Army Medical Research and Development Command, announced an agreement…